Muhoberac Barry B, Baraibar Martin A, Vidal Ruben
Department of Chemistry and Chemical Biology, Indiana University-Purdue University, Indianapolis, IN 46202, USA.
Biochim Biophys Acta. 2011 Apr;1812(4):544-8. doi: 10.1016/j.bbadis.2010.10.010. Epub 2010 Oct 26.
Hereditary ferritinopathy (HF) is a neurodegenerative disease characterized by intracellular ferritin inclusion bodies (IBs) and iron accumulation throughout the central nervous system. Ferritin IBs are composed of mutant ferritin light chain as well as wild-type light (Wt-FTL) and heavy chain (FTH1) polypeptides. In vitro studies have shown that the mutant light chain polypeptide p.Phe167SerfsX26 (Mt-FTL) forms soluble ferritin 24-mer homopolymers having a specific structural disruption that explains its functional problems of reduced ability to incorporate iron and aggregation during iron loading. However, because ferritins are usually 24-mer heteropolymers and all three polypeptides are found in IBs, we investigated the properties of Mt-FTL/FTH1 and Mt-FTL/Wt-FTL heteropolymeric ferritins. We show here the facile assembly of Mt-FTL and FTH1 subunits into soluble ferritin heteropolymers, but their ability to incorporate iron was significantly reduced relative to Wt-FTL/FTH1 heteropolymers. In addition, Mt-FTL/FTH1 heteropolymers formed aggregates during iron loading, contrasting Wt-FTL/FTH1 heteropolymers and similar to what was seen for Mt-FTL homopolymers. The resulting precipitate contained both Mt-FTL and FTH1 polypeptides as do ferritin IBs in patients with HF. The presence of Mt-FTL subunits in Mt-FTL/Wt-FTL heteropolymers also caused iron loading-induced aggregation relative to Wt-FTL homopolymers, with the precipitate containing Mt- and Wt-FTL polypeptides again paralleling HF. Our data demonstrate that co-assembly with wild-type subunits does not circumvent the functional problems caused by mutant subunits. Furthermore, the functional problems characterized here in heteropolymers that contain mutant subunits parallel those problems previously reported in homopolymers composed exclusively of mutant subunits, which strongly suggests that the structural disruption characterized previously in Mt-FTL homopolymers occurs in a similar manner and to a significant extent in both Mt-FTL/FTH1 and Mt-FTL/Wt-FTL heteropolymers.
遗传性铁蛋白病(HF)是一种神经退行性疾病,其特征是细胞内铁蛋白包涵体(IBs)以及整个中枢神经系统中的铁积累。铁蛋白IBs由突变型铁蛋白轻链以及野生型轻链(Wt - FTL)和重链(FTH1)多肽组成。体外研究表明,突变型轻链多肽p.Phe167SerfsX26(Mt - FTL)形成可溶性铁蛋白24聚体同聚物,具有特定的结构破坏,这解释了其在铁负载过程中结合铁能力降低和聚集的功能问题。然而,由于铁蛋白通常是24聚体杂聚物,并且在IBs中发现了所有三种多肽,我们研究了Mt - FTL/FTH1和Mt - FTL/Wt - FTL杂聚铁蛋白的性质。我们在此展示了Mt - FTL和FTH1亚基轻松组装成可溶性铁蛋白杂聚物,但它们结合铁的能力相对于Wt - FTL/FTH1杂聚物显著降低。此外,Mt - FTL/FTH1杂聚物在铁负载过程中形成聚集体,这与Wt - FTL/FTH1杂聚物形成对比,并且与Mt - FTL同聚物的情况相似。所得沉淀物包含Mt - FTL和FTH1多肽,就像HF患者的铁蛋白IBs一样。相对于Wt - FTL同聚物,Mt - FTL/Wt - FTL杂聚物中Mt - FTL亚基的存在也导致铁负载诱导的聚集,沉淀物中含有Mt - FTL和Wt - FTL多肽,这再次与HF情况相似。我们的数据表明,与野生型亚基的共组装并不能规避由突变亚基引起的功能问题。此外,这里在含有突变亚基的杂聚物中表征的功能问题与先前在仅由突变亚基组成的同聚物中报道的问题相似,这强烈表明先前在Mt - FTL同聚物中表征的结构破坏在Mt - FTL/FTH1和Mt - FTL/Wt - FTL杂聚物中以类似的方式且在很大程度上发生。